DoseMe to invest in EMR integration following capital raising

Medications dose individualisation software developer DoseMe is set to invest in commercialising the product in Australia and integrating it with electronic medical records as it prepares for entry into the US and European markets, following the successful closure of a $2.6 million Series A financing round.

Brisbane-based DoseMe, which was established in 2014 with seed funding from private investor Steve Baxter, is now valued at $20 million after it secured further funding from two local investors, Greg Spurgin and Gary Cunningham, who together co-founded an outpatient orthopaedic physical therapy company called Results Physiotherapy that has proved successful in the US.

Posted in Australian eHealth

Tags: DoseMe

You need to log in to post comments. If you don't have a Pulse+IT website account, click here to subscribe.

Sign up for Pulse+IT eNewsletters

Sign up for Pulse+IT website access

For more information, click here.

Copyright © 2022 Pulse+IT Communications Pty Ltd
No content published on this website can be reproduced by any person for any reason without the prior written permission of the publisher.
Supported by Social Media Agency | pepperit